Zuckerman D A, Sterling K M, Oser R F
Mallinckrodt Institute of Radiology, Jewish Hospital of St. Louis, MO 63110, USA.
J Vasc Interv Radiol. 1996 Mar-Apr;7(2):199-205. doi: 10.1016/s1051-0443(96)70762-5.
To examine the safety of pulmonary angiography with low-osmolar contrast material and modern angiographic techniques and to analyze periprocedural complications with respect to potential predictors.
A retrospective review was conducted of data from 547 consecutive patients who underwent pulmonary angiography. Minor and major complications were analyzed by using several clinical parameters.
There were five major (0.9%) and 26 minor complications (4.8%). Eleven of the 26 minor complications were contrast-induced nephrotoxicity. There were no periprocedural deaths. Patients with complications had an increased incidence of coexistent pulmonary morbidities and were of a poorer physical status according to the American Society of Anesthesiology criteria. Moderate to severe pulmonary hypertension was correlated with major complications. Age, volume of contrast material used, and presence of pulmonary embolism were not correlated with complications.
Pulmonary angiography is a safe procedure with an acceptable complication rate. These findings should be considered in the selection of an imaging method for the diagnosis of pulmonary embolism.
探讨低渗性对比剂及现代血管造影技术用于肺血管造影的安全性，并分析围手术期并发症及其潜在预测因素。
对547例连续接受肺血管造影的患者的数据进行回顾性分析。采用多种临床参数分析轻微和严重并发症。
有5例严重并发症（0.9%）和26例轻微并发症（4.8%）。26例轻微并发症中有11例为对比剂诱导的肾毒性。围手术期无死亡病例。发生并发症的患者并存肺部疾病的发生率更高，且根据美国麻醉医师协会标准，其身体状况较差。中重度肺动脉高压与严重并发症相关。年龄、所用对比剂的量及肺栓塞的存在与并发症无关。
肺血管造影是一种安全的检查方法，并发症发生率可接受。在选择诊断肺栓塞的成像方法时应考虑这些结果。
